GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The IBN SINA Pharmaceutical Industry PLC (DHA:IBNSINA) » Definitions » Debt-to-Revenue

The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Debt-to-Revenue : 0.00 (As of . 20)


View and export this data going back to . Start your Free Trial

What is The IBN SINA Pharmaceutical Industry Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

The IBN SINA Pharmaceutical Industry's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was BDT0.00 Mil. The IBN SINA Pharmaceutical Industry's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was BDT0.00 Mil. The IBN SINA Pharmaceutical Industry's annualized Revenue for the quarter that ended in . 20 was BDT0.00 Mil.


The IBN SINA Pharmaceutical Industry Debt-to-Revenue Historical Data

The historical data trend for The IBN SINA Pharmaceutical Industry's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The IBN SINA Pharmaceutical Industry Debt-to-Revenue Chart

The IBN SINA Pharmaceutical Industry Annual Data
Trend
Debt-to-Revenue

The IBN SINA Pharmaceutical Industry Semi-Annual Data
Debt-to-Revenue

Competitive Comparison of The IBN SINA Pharmaceutical Industry's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, The IBN SINA Pharmaceutical Industry's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The IBN SINA Pharmaceutical Industry's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The IBN SINA Pharmaceutical Industry's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where The IBN SINA Pharmaceutical Industry's Debt-to-Revenue falls into.


;
;

The IBN SINA Pharmaceutical Industry Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

The IBN SINA Pharmaceutical Industry's Debt-to-Revenue for the fiscal year that ended in . 20 is calculated as

The IBN SINA Pharmaceutical Industry's annualized Debt-to-Revenue for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is one times the quarterly (. 20) Revenue data.


The IBN SINA Pharmaceutical Industry Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of The IBN SINA Pharmaceutical Industry's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


The IBN SINA Pharmaceutical Industry Business Description

Traded in Other Exchanges
N/A
Address
Mirpur Road, Tanin Center, 3 Asad Gate, Mohammadpur, Dhaka, BGD, 1207
The IBN SINA Pharmaceutical Industry PLC is engaged in the production and marketing of pharmaceutical drugs and natural medicines in both the local and international market.

The IBN SINA Pharmaceutical Industry Headlines

No Headlines